RxDoctor Payments Data

Alexis Holder, PA

Physician Assistant · Austin, TXNPI 1346442365

Payments from drug & device makers

$17,671in general payments, 2019–2025

Across 986 payments — averaging $17.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • Lilly USA, LLC$2K
  • Amgen$1K
  • Radius Health, Inc.$943
  • AbbVie$893
  • AstraZeneca$783
  • plus $9K from 53 others

What the payments were for

  • Food & beverage$17,51499%
  • Education$981%
  • Gifts$590%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk143$2,379
Lilly USA, LLC138$2,313
Amgen(2 entities)81$1,474
Radius Health, Inc.48$943
AbbVie63$893
AstraZeneca(2 entities)40$783
Boehringer Ingelheim36$764
Bayer37$623
Sanofi-aventis U.S. LLC28$475
Amneal Pharmaceuticals LLC20$471
Mannkind Corporation25$460
IBSA Pharma Inc.33$459
Corcept Therapeutics28$408
Xeris Pharmaceuticals, Inc.20$370
Amarin Pharma, Inc.18$362
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC27$341
Medtronic21$328
Tandem Diabetes Care, Inc.13$297
Dexcom, Inc.11$273
Insulet Corporation17$239
Cequr Corporation3$189
Esperion Therapeutics, Inc.13$188
Astellas Pharma US Inc8$174
Recordati_rare_diseases_inc.8$165
Clarus Therapeutics Inc.8$157
Abbott5$154
Zealand Pharma US, Inc.5$144
Madrigal Pharmaceuticals5$138
Novartis8$130
Kyowa Kirin, Inc.5$116
BETA Bionics, Inc.4$101
Merck7$100
Ascendis Pharma Endocrinology Inc4$94
Ipsen Biopharmaceuticals, Inc5$90
Intuity Medical Inc6$89
Inspire Medical Systems, Inc.3$87
Alvogen Inc3$72
Regeneron Healthcare Solutions, Inc.4$69
Amryt Pharma Holdings Ltd3$64
Jazz Pharmaceuticals Inc.4$63
Sequel Med Tech, LLC2$61
GRT US Holding, Inc.2$59
Averitas Pharma Inc.2$47
Chiesi USA, Inc.2$47
Eisai Inc.2$45
Neurocrine Biosciences, Inc.2$44
Currax Pharmaceuticals LLC3$44
Althera Pharmaceuticals LLC2$41
RGH Enterprises LLC1$30
Rhythm Pharmaceuticals, Inc.1$30
Nevro Corp.1$28
Ascensia Diabetes Care US Inc.1$26
Globus Medical1$25
Itamar Medical Inc1$25
Tolmar, Inc.1$19
Shield Therapeutics Inc1$19
Pfizer1$16
Acerus Pharmaceuticals Corporation1$16
Alnylam Pharmaceuticals Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,671 in reported general payments places this provider in the 95th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$72,288
Medicare patients
312
Services billed
795

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide339$352,579
MounjaroTirzepatide290$346,533
FarxigaDapagliflozin Propanediol223$168,400
JardianceEmpagliflozin127$96,203
TrulicityDulaglutide53$77,553
JanuviaSitagliptin Phosphate70$44,321
RybelsusSemaglutide43$43,082
ProliaDenosumab20$35,109
CyclosetBromocriptine Mesylate36$32,395
Tresiba Flextouch U-100Insulin Degludec47$30,414
KerendiaFinerenone32$21,653
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog24$21,149
Tresiba Flextouch U-200Insulin Degludec13$20,194
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog41$19,189
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/715$14,798

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$2,313$424,086343 claims
Novo NordiskOzempic, Rybelsus, Novolog$2,379$399,310397 claims
AstraZenecaFarxiga$783$168,400223 claims
Boehringer IngelheimJardiance$764$96,203127 claims
MerckJanuvia$100$44,32170 claims
AmgenProlia$1,474$35,10920 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCCycloset$341$32,39536 claims
BayerKerendia$623$21,65332 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$475$10,77411 claims
AbbVieSynthroid$893$9,129108 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium, Unithroid$471$1,481163 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Austin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →